Publications for Helena Fohlin
Co-author map based on ISI articles 2007-
Publications mentioned in social media 20 times*
|Mourad El Ouali, Helena Fohlin and Anand Srivastav|
A randomised approximation algorithm for the hitting set problem
Theoretical Computer Science, 2014, 555, 23-34.
|Helena Fohlin, Gizeh Perez-Tenorio, Tommy Fornander, Lambert Skoog, Bo Nordenskjöld, John Carstensen and Olle Stål|
Akt2 expression is associated with good long-term prognosis in oestrogen receptor positive breast cancer
European Journal of Cancer, 2013, 49(6), 1196-1204.
Web of Science® Times Cited: 1
|Sverre Sörenson, Helena Fohlin, Andrea Lindgren, Magnus Lindskog, Bengt Bergman, Christer Sederholm, Lars Ek, Kristina Lamberg and Birgitta Clinchy|
Predictive role of plasma vascular endothelial growth factor for the effect of celecoxib in advanced non-small cell lung cancer treated with chemotherapy
European Journal of Cancer, 2013, 49(1), 115-120.
Web of Science® Times Cited: 2
|Andrea Koch, Bertil Gustafsson, Helena Fohlin and Sverre Sörenson|
Cyclooxygenase-2 expression in lung cancer cells evaluated by immunocytochemistry
Diagnostic Cytopathology, 2011, 39(3), 188-193.
Web of Science® Times Cited: 5
|Laszlo Tabar, Bedrich Vitak, Tony Hsiu-Hsi Chen, Amy Ming-Fang Yen, Anders Cohen, Tibor Tot, Sherry Yueh-Hsia Chiu, Sam Li-Sheng Chen, Jean Ching-Yuan Fann, Johan Rosell, Helena Fohlin, Robert A Smith and Stephen W Duffy|
Swedish Two-County Trial: Impact of Mammographic Screening on Breast Cancer Mortality during 3 Decades
Radiology, 2011, 260(3), 658-663.
Web of Science® Times Cited: 113
|Mahmoud R Khoshnoud, Britta Lofdahl, Helena Fohlin, Tommy Fornander, Olle Stål, Lambert Skoog, Jonas Bergh and Bo Nordenskjöld|
Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen
Breast Cancer Research and Treatment, 2011, 126(2), 421-430.
Web of Science® Times Cited: 14
|B. C. Sanchez, M. Sundqvist, Helena Fohlin, F. Spyratos, Bo Nordenskjöld, Olle Stål, B. K and Linderholm|
Prolonged tamoxifen treatment increases relapse-free survival for patients with primary breast cancer expressing high levels of VEGF
European Journal of Cancer, 2010, 46(9), 1580-1587.
Web of Science® Times Cited: 4
* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.